| | | |
Lower gastrointestinal (GI) bleeding is an important cause of increased morbidity and mortality in the elderly. Its incidence increases with age and corresponds to the increased incidence of specific GI diseases more common in the elderly, comorbid illnesses, and polypharmacy. GI illnesses associated with lower GI bleeding that are more common in the elderly include diverticulosis coli, vascular ectasia, ischemic colitis, and colonic neoplasms. Comorbid illnesses include atherosclerotic cardiovascular disease, cerebrovascular disease, and malignancy. The evaluation of patients is adjusted to the rate and severity of hemorrhage and the clinical status of the patient. The physical examination may be complicated by the presence of visual, auditory, and cognitive impairment. Timing of tests and the type of intervention should be custom-tailored, especially for the frail elderly patient. With appropriate evaluation and management, a successful outcome can be achieved in the majority of elderly patients with lower GI bleeding. (Annals of Long-Term Care: Clinical Care and Aging 2007;15[4]:40-45)
Click here to download full article in PDF format
INTRODUCTION
Lower gastrointestinal (GI) bleeding is a significant cause of increased morbidity and mortality in the elderly. The incidence of lower GI bleeding increases with age, with a greater than 200-fold increase from the third to the ninth decade of life. The incidence of lower GI bleeding in the United States ranges from 20.5 to 27 per 100,000 persons per year, and is more common in men than women.1 The increased incidence of lower GI bleeding in the elderly corresponds to the increased incidence of specific GI diseases, the increased incidence of comorbid illnesses, and more polypharmacy. GI illnesses associated with lower GI bleeding that are more common in the elderly include diverticulosis coli, vascular ectasia, ischemic colitis, and colonic neoplasms. Hemorrhage and the presence of serious concurrent illness are the two most important factors in predicting mortality among patients with GI bleeding.2 Comorbid illnesses include atherosclerotic cardiovascular disease, cerebrovascular disease, and malignancy. Anticoagulant and nonsteroidal anti-inflammatory drug (NSAID) use increases the probability of GI bleeding.
PATHOPHYSIOLOGY OF LOWER GI BLEEDING
Lower GI bleeding can be acute bleeding, occult bleeding, or obscure bleeding. Acute lower GI bleeding presents as melena or hematochezia. Occult bleeding is usually detected with stool guaiac testing and is the most common presentation of lower GI bleeding in the elderly, occurring in 10% of the adult population. Remarkably, patients losing 100 mL of blood per day may have grossly normal-appearing stools.3,4 Obscure bleeding is when the source of bleeding is difficult to detect on routine endoscopic and radiologic examinations. The source of bleeding is unidentified in approximately 5% of patients.5
CAUSES OF LOWER GI BLEEDING
There are many causes of lower GI bleeding in the elderly (Table I). The most common causes of lower GI bleeding are diverticular disease and vascular ectasias. Less common causes of lower GI bleeding are inflammatory diseases of the colon due to infectious colitis, ischemic colitis, idiopathic inflammatory bowel disease, post-irradiation colitis, neoplasms, postpolypectomy hemorrhage, and hemorrhoids. There are additional rarer causes that include Dieulafoy’s lesion and colorectal varices.6,7
Diverticulosis Coli
The incidence of diverticulosis coli increases with age from approximately 5% of individuals at age 40 to 65% at age 85.8 Although most patients with diverticulosis are asymptomatic, approximately 3-5% can develop lower GI bleeding, usually in the form of hematochezia.9 Diverticular disease is the most common cause of lower GI bleeding, with an incidence ranging from 15-48% of patients with lower GI bleeding, depending upon the series. Diverticular hemorrhage can be severe, with a significant morbidity rate of 10-20%. Risk factors for hemorrhage include the use of NSAIDs, lack of dietary fiber, constipation, and advancing age.10-12 Bleeding usually ceases spontaneously, with less than 1% of patients requiring greater than 4 units of blood.9 However, bleeding can become more hemodynamically significant in elderly patients with comorbid conditions, such as cerebrovascular disease or atherosclerotic cardiovascular disease, and in those with polypharmacy who may be taking anticoagulants or NSAIDs.
Vascular Ectasia
Vascular Ectasia or angiodysplasia can occur in the colon and small intestine. They occur with much greater frequency in the elderly than telangiectasia, hemangiomas, or congenital arteriovenous malformations. They are degenerative lesions of previously normal blood vessels that may occur anywhere in the colon, but are more common in the cecum and right colon. Small-bowel vascular ectasia are the most common source of obscure GI bleeding, comprising up to 60% of cases.13,14 Bleeding may manifest itself as iron-deficiency anemia and occult blood-positive stools. However, in up to 15% of patients, bleeding is massive.
Inflammatory Diseases of the Colon
The various types of inflammatory diseases of the colon can be indistinguishable upon initial presentation and endoscopic findings. The clinical presentation of abdominal pain, lower GI bleeding, fever, and dehydration are common to all. Endoscopically, the mucosa may appear edematous, friable, and ulcerated in any of the various types of colitis, although the characteristics specific to the various types of colitis can aid in diagnosis. The most common forms in the elderly are ischemic colitis, infectious colitis, idiopathic inflammatory bowel disease, and post-irradiation colitis.
Ischemic colitis accounts for 3-9% of all cases of lower GI bleeding in the elderly.1,15 Colonic atherosclerosis is almost universal in the elderly and predisposes to ischemic colitis. Ischemic colitis results from reduced blood supply to the colon from hypotension, embolic events, or anatomic or functional changes in the mesenteric vasculature. Most often, the precipitating event or factors leading to the lesion cannot be identified. However, a history of a hypotensive event supports the diagnosis. Patients often present with lower abdominal cramping type of pain, followed by hematochezia or bloody diarrhea. Bleeding is rarely severe. It may be complicated by perforation or stricture formation that may necessitate surgery, including hemicolectomy.16
The elderly have a greater risk for infectious colitis and its complications than younger populations.17 In addition, the mortality from infectious colitis increases with age.18 The most common causes of enteric infections in the elderly are Campylobacter, Salmonella, Shigella, Escherichia coli 0157:H7, and Clostridium difficile.19 C. difficile as a cause of diarrhea and lower GI bleeding must be considered in elderly patients in long-term care facilities and hospitals, and in all patients who have recently been treated with antibiotics. Infectious colitis is suggested following the consumption of undercooked fish or meat and during outbreaks of bloody diarrhea in the community, and certainly in long- term care facilities or hospitals. E. coli 0157:H7 has significant complications, such as acute thrombotic thrombocytopenic purpura and death in the elderly. Bleeding is rarely massive in patients with infectious colitis, with hematochezia noted in less than 10% of cases.20
Idiopathic inflammatory bowel disease (IBD) can occur in the elderly, although with much less frequency than in younger persons. It is less common than ischemic bowel disease in the elderly. There is a bimodality in the incidence of IBD, with a second peak occurring between the ages of 60 and 70.21 Approximately 15% of all patients with inflammatory bowel disease develop symptoms after the age of 65.21,22 Although GI bleeding is common with IBD, severe hematochezia is infrequent. Lower GI bleeding in IBD accounts for hospitalizations in 6% of patients with Crohn’s disease and 1.4-4.2% of patients with ulcerative colitis.23,24
Post-irradiation colitis can be a source of lower GI bleeding in the elderly population, with a greater incidence of malignancy requiring irradiation. It can present as occult or massive bleeding, or chronic iron deficiency anemia.
Neoplasms
Benign and malignant neoplasms of the colon and rectum are a cause of lower GI bleeding in 10-20% of cases in elderly patients.25 Bleeding is the initial presenting symptom in up to 26% of patients with colorectal neoplasms.26,27 Although bleeding is usually occult or mild, it may rarely present as massive bleeding if there is erosion into a large vessel or if the patient is taking anticoagulants or NSAIDs. Bleeding may often be associated with constipation or diarrhea, a change in stool caliber, or weight loss.
Post-Polypectomy Bleeding
Bleeding is a complication of colonoscopic polypectomy in approximately 0.7-2.5% of cases and is the source of bleeding in approximately 3% of patients.28,29 It more commonly follows sessile polyp removal. Hematochezia usually develops soon after polypectomy, but may be delayed in some cases for up to 1 week after the procedure.30
Hemorrhoids
Hemorrhoids are a common source of bleeding in elderly patients with intermittent and low-volume hematochezia, which often only coats the stool.
Comorbid Illness
After hemorrhage, the presence of the serious concurrent illness is the second most important factor in predicting mortality among patients with GI bleeding.2 These include cardiovascular disease, cerebrovascular disease, and malignancy. Atherosclerotic cardiovascular disease is a cause of ischemic bowel disease. Atherosclerotic heart disease with atrial fibrillation is associated with embolic events to the intestine leading to ischemic bowel disease. Aortic valvular disease is associated with vascular ectasia of the colon.
Polypharmacy
The increased use of medications, such as anticoagulants and NSAIDs, among elderly persons as compared to younger individuals increases the probability of GI bleeding. Elderly patients with arthritis often use NSAIDs to a great degree, which not only causes upper GI ulceration, but also ulceration of the small intestine and colon that may bleed. Additionally, NSAIDs and anticoagulants can increase hemorrhage due to their effect on platelet function and blood-clotting factors.
CLINICAL COURSE AND DIAGNOSTIC EVALUATION
The clinical course can vary widely in elderly patients with lower GI bleeding from occult bleeding to massive life-threatening hemorrhage and death. It is often complicated by comorbidities and polypharmacy. Therefore, the evaluation is adjusted to the rate and severity of hemorrhage and the clinical status of the patient. A detailed history and physical examination is important, but may be complicated by the presence of visual, auditory, and cognitive impairment. It may be necessary to confer with the primary care provider, caregiver, and perhaps even the pharmacist to obtain history, such as extent of bleeding, duration of symptoms, presence of comorbid illnesses, prior surgical history, known drug allergies, and recent and current medication use, such as clopidogrel, warfarin, and NSAIDs. Common presenting symptoms for illnesses may not be evident. For example, in elderly patients taking NSAIDs, abdominal pain may not be a significant presenting complaint, and painless hemorrhage that may be life-threatening can occur.31-33
Physical examination to assess the severity of bleeding and status of the patient is important, with emphasis on the presence of orthostatic changes, signs of cardiopulmonary compromise, stigmata of chronic liver disease, and evidence of coagulopathy. In cognitively impaired patients, a Mini-Mental State Examination is indicated on or after admission, if feasible. Informed consent to procedures may be difficult to obtain in patients who suffer from cognitive dysfunction. With the exception of a true life-threatening emergency, every attempt should be made to obtain consent for testing procedures from the patient, if competent, or the surrogate. In the case when a guardian cannot be reached, administrative consent should be obtained.34
In patients with mild, chronic, or occult bleeding with iron-deficiency anemia, workup can be performed in a hospital or outpatient setting, depending on the clinical state of the patient. The timing of tests and the type of intervention should be custom-tailored, especially for the frail elderly patient, depending upon functional status, its impact on outcome, and the available diagnostic strategies. The various interventions considered should not be withheld because of age alone (Table II).
In the majority of cases, lower GI bleeding stops spontaneously with appropriate resuscitation and supportive care. However, in some cases it may be life-threatening and require endoscopic, radiologic, or surgical intervention. Since approximately 10-15% of patients presenting with hematochezia may have an upper GI source of bleeding, it is important to rule out an upper GI bleeding source in these patients.35,36
Urgent colonoscopy performed within 24 hours of hospitalization following a rapid purge is the best test for evaluation of lower GI bleeding, once the patient has been resuscitated and hemodynamically stabilized.37 In patients with active bleeding where colonoscopy is not feasible due to massive bleeding, radionuclide imaging and abdominal angiography can help identify the source of bleeding.38,39
There are important considerations involving diagnostic and treatment methods in elderly patients. Older patients are more likely to have pacemakers with or without defibrillators. Recommendations for management of patients who require endoscopy and have pacemakers and internal defibrillators are not well defined. Cardiology consultation may often be indicated. Alternative means of tissue removal, destruction, or hemostasis should be considered to simplify management of patients to control hemorrhage with defibrillators, such as hemo-clips, ligation devices, and injection of epinephrine and sclerosing agents. The general principle of geriatric pharmacology of starting with low doses of medication and slowly advancing to larger doses is an important dictum in conscious sedation of the elderly during endoscopy. Initial dosages should be lower, and titration should be more gradual.40
It is estimated that 5% of patients with GI bleeding, whether occult or overt, will have a negative upper GI endoscopy and colonoscopy. This scenario of obscure bleeding is more common in older patients.41 Radionuclide scanning and abdominal arteriography may be helpful when bleeding is sufficient to reveal a lesion.
Newer endoscopic methods are available for evaluation of the small intestine, which may be an important source of either overt or occult bleeding in the elderly. Wireless capsule endoscopy is a useful tool for the diagnosis of obscure GI bleeding, enabling noninvasive visualization of the entire small intestine.42 Push enteroscopy and double-balloon enteroscopy can also be helpful in both the evaluation and treatment of obscure GI bleeding from the small intestine.43
TREATMENT
After initial evaluation, colonoscopy provides not only the best method of evaluation, but also the best method for treating patients with lower GI bleeding. Colonoscopy provides many methods for controlling hemorrhage, including heater probe or bipolar probe thermal coagulation, band ligation, argon plasma coagulation, metallic clips, epinephrine and sclerosing agent injection, and fibrous glue.
For persistent bleeding not amenable to control by colonoscopic methods, abdominal angiography with infusion of vasopressin or embolization of the bleeding vessel is successful in about 90% of cases. Embolization with polyvinyl alcohol particles or microcoils provides more definitive means of controlling the bleeding, but may be complicated by intestinal infarction in up to 20% of patients.44 In addition, bleeding recurrence is 50%, and intolerance of the cardiovascular complications of vasopressin is common in the elderly.45,46
Patients who fail angiographic or endoscopic therapy may require surgery. Every effort should be made to identify the bleeding source prior to referral for surgery, which often requires a blind segmental colectomy and carries a significant risk of complications in the elderly. A positive preoperative angiogram for regional localization reduces the risk of rebleeding.45 Blind segmental resection is associated with a rebleeding rate of 47% and morbidity and mortality rate of 83% and 57%, respectively.47-52
There are specific issues in the elderly population with comorbidities and polypharmacy. For example, metronidazole used to treat C. difficile colitis may interfere with oxidation of warfarin and induce excessive anticoagulation. General principles for treatment of elderly patients with IBD are the same as for younger patients, although no studies specifically for the elderly population are available. There are significant complications, however, from treatment of IBD in the elderly. For example, osteoporosis is a significant problem in the elderly patients with IBD taking corticosteroids. Older patients with IBD taking these agents must be evaluated for osteoporosis and offered prophylaxis with agents such as biphosphonates and calcium with vitamin D.53
In the majority of patients with lower GI bleeding, bleeding is controlled or ceases spontaneously, with less than 1% of patients requiring a transfusion of greater than 4 units of blood.9 Jensen et al22 reported no rebleeding during a 30-month follow-up after endoscopic therapy when compared to a 53% rebleeding rate in patients treated with conservative medical therapy alone. However, despite improvements of localization of bleeding and targeted treatment of lesions, the mortality rate for severe bleeding remains 10%.45
CONCLUSION
Lower GI bleeding is a significant cause of increased morbidity and mortality in the elderly population. The incidence increases with age and corresponds to the increased incidence of specific GI diseases more common in the elderly, the increased incidence of comorbid illness in this population, and polypharmacy, which is more common in the elderly. With appropriate evaluation and management, a successful outcome will be achieved in the majority of elderly patients with lower GI bleeding.
The author reports no relevant financial relationships.
|
References
1. Longstreth GF. Epidemiology and outcome of patients hospitalized with acute lower gastrointestinal hemorrhage: A population -based study. Am J Gastroenterol 1997;92:419-424.
2. Turner IB, Jones M, Piper DW. Factors influencing mortality from bleeding peptic ulcers. Scand J Gastroenterol 1991;6:661-666.
3. Schiff L, Stevens RJ, Shapiro N, Goodman S. Observations on the oral administration of citrate blood in man. Effect on stools. Am J Med Sci 1942;203:409.
4. Rockey DC. Occult gastrointestinal bleeding. N Engl J Med 1999;341:38-46.
5. Mujica VR, Barkin JS. Occult gastrointestinal bleeding. General overview and approach. Gastrointest Endosc Clin North Am 1996;6:833-845.
6. Vernava AM 3rd, Moore BA, Longo WE, Johnson FE. Lower gastrointestinal bleeding. Dis Colon Rectum 1997;40:844-858.
7. Jensen DM, Machicado GA. Colonoscopy for diagnosis and treatment of severe lower gastrointestinal bleeding. Routine outcomes and cost analysis. Gastrointest Endosc Clin N Am 1997;7:477-498.
8. Painter NS, Burkitt, DP. Diverticular disease of the colon, a 20th century problem. Clin Gastroenterol 1975;4:3-21.
9. McGuire HH Jr. Bleeding colonic diverticula. A reappraisal of natural history and management. Ann Surg 1994;220:653-656.
10. Bjarnason I, MacPherson AJ. Intestinal toxicity of non-steroidal anti-inflammatory drugs. Pharmacol Ther 1994;62:145-157.
11. Wilcox CM, Alexander LN, Cotsonis GA, Clark WS. Nonsteroidal antiinflammatory drugs are associated with both upper and lower gastrointestinal bleeding. Dig Dis Sci 1997;42:990-997.
12. Meyers MA, Alonso DR, Gray GF, Baer JW. Pathogenesis of bleeding colonic diverticulosis. Gastroenterology 1976;71:577-583.
13. Foutch PG. Angiodysplasia of the gastrointestinal tract. Am J Gastroenterol 1993;88:807-818.
14. Descamps C, Schmit A, Van Gosssum A. “Missed” upper gastrointestinal tract
lesions may explain “occult” bleeding. Endoscopy 1999;31:452-455.
15. Bramley P, Masson JW, McKnight G, et al. The role of an open-access bleeding unit in the management of colonic hemorrhage. A 2-year prospective study. Scand J Gastroenterol 1996;31:764-769.
16. Brandt LJ, Boley SJ, Mitsudo S. Clinical characteristics and natural history of colitis in the elderly. Am J Gastroenterol 1982;77:382-386.
17. Jensen DM, Machicado GA, Jutabha R, Kovacs TO. Urgent colonoscopy for the diagnosis and treatment of severe diverticular hemorrhage. N Engl J Med 2000;342:78-82.
18. Lew JF, Glass RI, Gangarosa RE, et al. Diarrheal deaths in the United States, 1979 through 1987. A special problem for the elderly. JAMA 1991;265:3280-3284.
19. Guerrant RL, Van Gilder T, Steiner PS, et al; Infectious Diseases Society of America. Practice guidelines for the management of infectious diarrhea. Clin Infect Dis 2001;32:331-351.
20. Slotwiner-Nie PK, Brandt LJ. Infectious diarrhea in the elderly. Gastroenterol Clin North Am 2001;30:625-635.
21. Linder AE. Inflammatory bowel disease in the elderly. Clin Geriatr Med 1999;15:487-497.
22. Robertson DJ, Grimm IS. Inflammatory bowel disease in the elderly. Gastroenterol Clin North Am 2001;30:409-429.
23. Robert JH, Sachar DB, Aufses AH, Greenstein AJ. Management of severe hemorrhage in ulcerative colitis. Am J Surg 1990;159:550-555.
24. Farmer RG, Hawk WA, Turnbull RB,Jr. Clinical patterns in Crohn’s diseases: A statistical study of 615 cases. Gastroenterology 1975;68(4 Pt 1):627-635.
25. Boley SJ, DiBiase A, Brandt LJ, Sammartano R. Lower intestinal bleeding in the elderly. Am J Surg 1979;137:57-64.
26. Peura DA, Lanza FL, Gostout CJ, Foutch PG. The American College of Gastroenterology Bleeding Registry: Preliminary findings. Am J Gastroenterol 1997;92:924-928.
27. Richter JM, Christensen MR, Kaplan LM, Nishioka NS. Effectiveness of current technology in the diagnosis and management of lower gastrointestinal hemorrhage. Gastrointest Endosc 1995;41:93-98.
28. Bender JS, Wiencek RG, Bouwman DL. Morbidity and mortality following total abdominal colectomy for massive lower gastrointestinal bleeding. Am Surg 1991;57:536-541.
29. Muhldorfer SM, Kekos G, Hahn EG, Ell C. Complications of therapeutic gastrointestinal endoscopy. Endoscopy 1992;24:276-283.
30. Rex DK, Lewis BS, Waye JD. Colonoscopy and endoscopic therapy for delayed post-polypectomy hemorrhage. Gastrointestinal Endosc 1992:38:127-129.
31. Segal WN, Cello JP. Hemorrhage in the upper gastrointestinal tract in the older patient. Am J Gastroenterol 1997;92:42-46.
32. Clinch D, Banerjee AK, Ostick G. Absence of abdominal pain in elderly patients with peptic ulcer. Age Ageing 1984;13:120-123.
33. Hilton D, Iman N, Burke GJ, et al. Absence of abdominal pain in older persons with endoscopic ulcers: A prospective study. Am J Gastroenterol 2001;96:380-384.
34. Informed consent for gastrointestinal endoscopy. Gastrointest Endosc 1988;34(3 Suppl):26S-27S.
35. Jensen DM, Machicado GA. The diagnosis and treatment of severe hematochezia. The role of urgent colonoscopy after purge. Gastroenterology 1988;95:1569-1574.
36. Cuellar RE, Gavaler JS, Alexander JA, et al. Gastrointestinal tract hemorrhage. The value of a nasogastric aspirate. Arch Intern Med 1990;150:1381-1384.
37. Elta GH. Urgent colonoscopy for acute lower GI bleeding. Gastrointest Endosc 2004;59:402-408.
38. Zuckerman DA, Bocchini TP, Birnbaum EH. Massive hemorrhage in the lower gastrointestinal tract in adults: Diagnostic imaging and intervention. AJR Am J Roentgenol 1993;160:703-711.
39. Dusold R, Burke K, Carpentier W, Dyck WP. The accuracy of technetium-99mlabeled red cell scintigraphy in localizing gastrointestinal bleeding. Am J Gastroenterol 1994;89:345-348.
40. Modifications in endoscopic practice for the elderly. American Society for Gastrointestinal Endoscopy. Gastrointest Endosc 2000;52:849-851.
41. Gralnek IM. Obscure-overt gastrointestinal bleeding. Gastroenterology 2005;128:1424-1430.
42. Hartmann D, Schmidt H, Bolz G, et al. A prospective two-center study comparing wireless capsule endoscopy with intraoperative enteroscopy in patients with obscure GI bleeding. Gastrointest Endosc 2005;61:826-832.
43. Saurin JC, Delvaux M, Vahedi K, et al. Clinical impact of capsule endoscopy: 1year follow-up study. Endoscopy 2005;37:318-323.
44. Guy GE, Shetty PC, Sharma RP, et al. Acute lower gastrointestinal hemorrhage: Treatment by superselective embolization with polyvinyl alcohol particles. AJR Am J Roentgenol 1992;159:521-526.
45. Browder W, Cerise EJ, Litwin MS. Impact of emergency angiography in massive lower gastrointestinal bleeding. Ann Surg 1986;204:530-536.
46. Sherman LM, Shenoy SS, Cerra FB. Selected intra-arterial vasopressin: clinical efficacy and complications. Ann Surg 1979;189:298-302.
47. Bokhari M, Vernava, AM, Ure T, Longo WE. Diverticular hemorrhage in the elderly-is it well tolerated? Dis Colon Rectum 1996;39:191-195.
48. Parkes BM, Obeid FN, Sorensen VJ, et al. The management of massive lower gastrointestinal bleeding. Am Surg 1993;59:676-678.
49. Stabile PE, Stamos MJ. Surgical management of gastrointestinal bleeding. Gastroenterol Clin North Am 2000;29:189-222.
50. Zuccaro G Jr. Management of the adult patient with acute lower gastrointestinal bleeding. American College of Gastroenterology. Practice Parameters Committee. Am J Gastroenterol 1998;93:1202-1208.
51. Setya V, Singer JA, Minken SL. Subtotal colectomy as a last resort for unrelenting, unlocalized, lower gastrointestinal hemorrhage: Experience with 12 cases. Am Surg 1992;58:295-299.
52. Gianfrancisco JA, Abcarian H. Pitfalls in the treatment of massive lower gastrointestinal bleeding with “blind” subtotal colectomy. Dis Colon Rectum 1982;25:441-445.
53. Lichtenstein GR, Sands BE, Pazianas M. Prevention and treatment of osteoporosis in inflammatory bowel disease. Inflamm Bowel Dis 2006;12:797-813.
|
| Annals of Long-Term Care - ISSN: 1524-7929 - Volume 15 - Issue 4 - April 2007 - Pages: 40 - 45 | |